Nick Sullivan
A bit about me Nick brings a clear, pragmatic strategic vision focused on innovation, integrated evidence generation, and alignment with […]
Nick Sullivan Appointed New Chief Executive Officer of Kintiga
A recognised leader in Market Access and HEOR, Nick Sullivan brings more than two decades of technical, operational, and business building expertise With this appointment, Kintiga is strengthening its leadership to deliver
Liz Welman
A bit about me I am a qualified solicitor, mum of two, South African-born doctor in law and I am
Annouk Verheecke
A bit about me Annouk is motivated by the opportunity to understand the needs of patients and healthcare stakeholders and
Frone Vandewiele
A bit about me I am passionate about improving health outcomes by enabling acceleration in patient access to innovative medicines. Career Highlights
Thomas Desmet
A bit about me I am passionate about contributing to ensure equal and timely access for patients to treatments and
Antonia Cybulski
A bit about me I enjoy contributing to the patient access to medicines and to keep learning everyday about market
The EU Pharmaceutical Package: Political Agreement and Strategic Consequences
Author: Florian Stieglitz, Consultant, Market Access From Proposal to Political Agreement Nearly three years after the European Commission presented its proposal
Structural Shifts in German Pharmaceutical Regulation: Policy Alignment, Data Integration, and Evolving Cost Pressure
Author: Florian Stieglitz, Consultant, Market Access The German pharmaceutical policy landscape is currently changing in numerous ways. Developments originating from
